PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Nielsen, Jens Cosedis
TI  - MANTRA-PAF
DP  - 2015 Dec 09
TA  - MD Conference Express
PG  - 8--9
VI  - 15
IP  - 28 suppl 2
4099  - http://mdc.sagepub.com/content/15/28_suppl_2/8.short
4100  - http://mdc.sagepub.com/content/15/28_suppl_2/8.full
AB  - At 5 years, patients in the MANTRA-PAF trial treated with radiofrequency ablation had less atrial fibrillation burden and episodes of symptomatic atrial fibrillation compared with antiarrhythmic drug. However, there was no significant difference in quality of life measures.